Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Current Protocols in Microbiology|November 5, 2014
Laboratory Maintenance of Acinetobacter baumanniiAnna C Jacobs, Daniel V ZurawskiScientific Reports|February 26, 2016
Evaluation of Parameters for High Efficiency Transformation of Acinetobacter baumanniiSuleyman Yildirim, Mitchell G Thompson, Anna C Jacobs, et al.Current Protocols in Microbiology|November 5, 2014
Genetic Manipulation of Acinetobacter baumanniiAnna C Jacobs, Mitchell G Thompson, Michael Gebhardt, et al.Antibiotics (Basel, Switzerland)|April 5, 2020
Monoclonal Antibodies as an Antibacterial Approach Against Bacterial PathogensDaniel V Zurawski, Molly K McLendonMolecular Microbiology|February 27, 2003
SseA acts as the chaperone for the SseB component of the Salmonella Pathogenicity Island 2 transloconDaniel V Zurawski, Murry A SteinACS Medicinal Chemistry Letters|January 21, 2017
1,2,4-Triazolidine-3-thiones as Narrow Spectrum Antibiotics against Multidrug-Resistant Acinetobacter baumanniiWilliam M Huggins, Bradley M Minrovic, Brendan W Corey, et al.Microbiology (Reading, England)|July 17, 2004
The SPI2-encoded SseA chaperone has discrete domains required for SseB stabilization and export, and binds within the C-terminus of SseB and SseDDaniel V Zurawski, Murry A SteinMedchemcomm|March 13, 2018
Narrow-Spectrum Antibacterial AgentsRoberta J Melander, Daniel V Zurawski, Christian MelanderFrontiers in Microbiology|March 3, 2020
Characterization of Acinetobacter baumannii Copper Resistance Reveals a Role in VirulenceCaitlin L Williams, Heather M Neu, Yonas A Alamneh, et al.ACS Infectious Diseases|November 5, 2016
1,2,4-Triazolidine-3-thiones Have Specific Activity against Acinetobacter baumannii among Common Nosocomial PathogensBrendan W Corey, Mitchell G Thompson, Lauren E Hittle, et al.Pageof 7